1.
Org Lett
; 26(13): 2535-2539, 2024 Apr 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38526435
RESUMO
Using readily available manganese pentacarbonyl bromide as a regeneration catalyst, biomimetic asymmetric reduction of imines including quinoxalinones, benzoxazinones, and benzoxazine has been successfully developed in the presence of transfer catalyst chiral phosphoric acids, providing the chiral amines with high yields and enantioselectivities.